Access brought to you by: LOCKSS

Rheumatoid Arthritis

The Risk of Lymphoma in Patients Receiving Anti-TNF Therapy for RA: Results from the BSR Biologics Register
Head-to-Head Biologics Trial Shows No Difference between Abatacept and Adalimumab
Etanercept Proves Clinically Superior to Discontinuation: Results from the DOSERA Trial
IMPROVED: Final Study Results of Combination Treatment in Patients with Early RA and UA
Short- and Long-Term Efficacy of Tofacitinib in the Treatment of Patients with RA and an Inadequate Response to TNF Inhibitors
SC Tocilizumab Reduces RA Disease Activity When Used with DMARDs
Update on Safety Issues in the Treatment of Rheumatic Diseases
Anti-TNF Therapy and CV Risk in RA
Towards Imaging Remission: Determining an MRI Inflammatory Activity-Acceptable State in RA
Update on ACR/EULAR RA Classification Criteria: What Have We Learned?

Pages